IRIS
SPAGNUOLO, ROCCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.025
AS - Asia 1.613
EU - Europa 1.214
SA - Sud America 416
OC - Oceania 47
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.359
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.941
SG - Singapore 701
IT - Italia 497
BR - Brasile 315
CN - Cina 299
DE - Germania 230
VN - Vietnam 216
IN - India 138
GB - Regno Unito 133
FI - Finlandia 110
NL - Olanda 51
SE - Svezia 50
CA - Canada 49
HK - Hong Kong 46
AR - Argentina 39
AU - Australia 39
ID - Indonesia 22
IR - Iran 22
MX - Messico 21
BD - Bangladesh 19
FR - Francia 19
EC - Ecuador 18
IQ - Iraq 18
KH - Cambogia 18
PL - Polonia 17
RO - Romania 15
MY - Malesia 13
RU - Federazione Russa 13
TR - Turchia 13
CO - Colombia 12
AT - Austria 11
CL - Cile 11
TH - Thailandia 11
ES - Italia 10
JP - Giappone 10
PK - Pakistan 10
NZ - Nuova Zelanda 8
ZA - Sudafrica 8
ET - Etiopia 7
KR - Corea 7
UA - Ucraina 7
VE - Venezuela 7
IE - Irlanda 6
LV - Lettonia 6
MA - Marocco 6
PH - Filippine 6
PY - Paraguay 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
GR - Grecia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
YE - Yemen 5
DZ - Algeria 4
TN - Tunisia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CH - Svizzera 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LB - Libano 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
CU - Cuba 2
EG - Egitto 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LC - Santa Lucia 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 5.358
Salva come PNG Salva come JPEG
Città #
San Jose 367
Singapore 285
Ashburn 210
Chandler 191
Munich 176
Dallas 129
Santa Clara 102
Ho Chi Minh City 95
Bengaluru 94
Milan 92
Hefei 91
Chicago 61
Helsinki 61
London 57
Beijing 50
Lawrence 50
Princeton 50
Catanzaro 48
Hong Kong 42
Turku 41
Boardman 40
São Paulo 38
Hanoi 35
New York 33
Rome 31
Los Angeles 26
Council Bluffs 23
Wilmington 23
Edinburgh 22
Phnom Penh 18
Des Moines 16
Rio de Janeiro 16
Sydney 14
Amsterdam 12
Redwood City 11
Chennai 10
Mexico City 10
Montreal 10
Nuremberg 10
Palermo 10
Redmond 10
San Francisco 10
Warsaw 10
Hamilton 9
Toronto 9
Biên Hòa 8
Boston 8
Brooklyn 8
Christchurch 8
San Nicola Manfredi 8
Tokyo 8
Adelaide 7
Atlanta 7
Brisbane 7
Campinas 7
Da Nang 7
Florence 7
Fortaleza 7
Guangzhou 7
Guayaquil 7
Hanover 7
Hải Dương 7
Mumbai 7
Naples 7
Shanghai 7
Turin 7
Belo Horizonte 6
Brasília 6
Buffalo 6
Campo Bom 6
Hortolândia 6
Jakarta 6
Norwalk 6
Orem 6
Pattaya 6
Perth 6
Riga 6
Seattle 6
Taranto 6
Bari 5
Bắc Giang 5
Catania 5
Collegeville 5
Curitiba 5
Delhi 5
Dhaka 5
Goiânia 5
Horia 5
Jyväskylä 5
Kingston 5
Manchester 5
Olomouc 5
Ottawa 5
Phoenix 5
Provo 5
Sanaa 5
Santiago de Cali 5
Stockholm 5
Tashkent 5
Verona 5
Totale 3.084
Salva come PNG Salva come JPEG
Nome #
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 304
BETA-GLUCAN, INOSITOL AND DIGESTIVE ENZYMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH IRRITABLE BOWEL SYNDROME 251
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 247
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 123
Patient Reported Outcomes come strumento infermieristico nella gestione delle Malattie Infiammatorie Croniche Intestinali (MICI): Sintomi Gastrointestinali e Alterazioni Psicosociali. 79
Anti interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report. 76
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 74
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 74
Acceptability of endoscopic procedures and patients' willingness to repeat them: a single-centre nursing study of influential factors 74
DIAPHRAGMATIC REHABILITATION IN GASTROOESOPHAGEAL REFLUX DISEASE 74
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 74
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 73
The role of gluten-free diet in nonalcoholic fatty liver disease development 73
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 72
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 70
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 69
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 68
Effects of a Portfolio-Mediterranean Diet and a Mediterranean Diet with or without a Sterol-Enriched Yogurt in Individuals with Hypercholesterolemia 67
L’epatopatia alcolica: dal danno alla terapia 65
COMPARISON BETWEEN DIFFERENT BOWEL PREPARATION REGIMENS FOR COLONOSCOPY: A SINGLE-CENTRE STUDY 65
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 64
OUTCOME OF ARTHRALGIA IN A SUBGROUP OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTI-TNF-ALPHA. A SINGLE CENTRE STUDY 64
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review 62
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 61
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 61
Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challenge 61
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 60
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 59
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 58
Exome-wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated with Fatty Liver Disease 58
Impact of Nursing Interventions via Telephone and Email on the Quality of Life of Patients with Inflammatory Bowel Disease: Preliminary Results of a Comparative Observational Study 57
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 57
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 56
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 56
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases 56
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 55
C-reactive protein induces tissue factor expression and promotes smooth muscle cells and endothelial cell proliferation 55
Nursing issues in enteral nutrition during prone position in critically ill patients: A systematic review of the literature 55
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 55
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 54
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. 54
The role of Neopterin in cardiovascular disease 54
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies 53
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 53
OBSERVING THE INFLUENCE OF SHAME AND GUILT IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW 52
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 52
Psychometric evaluation of an Italian custom 4-item short form of the PROMIS anxiety item bank in immune-mediated inflammatory diseases: An item response theory analysis 52
Nursing communication as a tool for patient satisfaction. A single hospital survey 51
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 51
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 50
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. 50
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 49
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 49
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 49
W1173 An In Vivo Study to Evaluate {MLCK} Expression in Patients with Inflammatory Bowel Diseases 48
Visualization of Comorbidities in Inflammatory Bowel Diseases through Networks 48
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 48
Lived Experiences of Patients With Inflammatory Bowel Disease in Italy: A Phenomenological Investigation 48
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 48
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 46
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 46
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 46
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 46
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 46
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 44
Pyoderma Gangrenosum and inflammatory bowel disease: a combined medical and surgical approach - case report and literature review 44
Effect of excess body weight on the genetic susceptibility to cancer. 44
Surgery for a gastric Dieulafoy's lesion reveals an occult bleeding jejunal diverticulum. A case report. 44
HIGH DIAGNOSTIC YIELD OF HISTOLOGICAL ANALYSIS OF EUS FINE-NEEDLE ASPIRATION BIOPSY INCLUDED IN FORMALIN WITHOUT ON-SITE CYTOPATHOLOGIC EXAMINATION. A RETROSPECTIVE STUDY 42
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 41
Pro-atherothrombotic effects of sigarette smoking in endothelial cells. Protective effects of statins 41
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 40
Milk thistle, Sylibum marianum 40
Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 40
Esophageal rupture after Heimlich maneuver: a case report and literature review 39
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study 39
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 39
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 38
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 38
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study 38
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 37
Milk Thistle, Silybum marianum 36
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 35
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 33
Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: A nursing-led cross-sectional study of patients in clinical remission 33
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 31
MBOAT7 in liver and extrahepatic diseases 31
Cross talk between liver and adipose tissue: A new role for PNPLA3? 27
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 25
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 24
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 23
Functional disorders of the upper digestive tract: epidemiological, clinical and therapeutic aspects 19
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features 15
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 15
Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension 14
A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties 13
107 Results From the {\textquotedblleft}{GLUTOX}{\textquotedblright} Trial: A Randomised, Double Blind, Placebo Controlled Crossover Study on {\textquotedblleft}Non Celiac Gluten Sensitivity{\textquotedblright} 11
Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study 10
Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis 10
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC) 5
Totale 5.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.611
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 5 4 13
2021/2022208 7 1 6 41 16 8 9 39 15 35 22 9
2022/2023672 104 52 23 64 56 47 19 73 86 47 64 37
2023/2024552 94 68 49 32 41 94 25 44 22 14 15 54
2024/20251.288 139 41 39 44 94 148 127 77 158 41 144 236
2025/20262.548 168 276 309 414 280 134 365 170 291 141 0 0
Totale 5.523